PMV Pharmaceuticals, Inc.
PMVP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$58,709 | -$68,960 | -$73,317 | -$57,846 |
| Dep. & Amort. | $1,144 | $1,257 | $650 | $1,281 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $12,375 | $0 | $0 |
| Change in WC | -$1,592 | $5,427 | -$568 | $4,123 |
| Other Non-Cash | $7,875 | -$5,756 | $9,475 | $5,871 |
| Operating Cash Flow | -$51,282 | -$55,657 | -$63,760 | -$46,571 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$655 | -$962 | -$7,984 | -$1,349 |
| Net Acquisitions | $251 | $0 | $0 | $0 |
| Inv. Purchases | -$148,286 | -$220,539 | -$229,199 | -$256,845 |
| Inv. Sales/Matur. | $202,042 | $170,956 | $235,815 | $114,610 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $53,352 | -$50,545 | -$1,368 | -$143,584 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $313 | $35,121 | $958 | $2,022 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $456 | $0 | $0 |
| Financing Cash Flow | $313 | $35,577 | $958 | $2,022 |
| Forex Effect | -$35 | $34 | $0 | $0 |
| Net Chg. in Cash | $2,348 | -$70,591 | -$64,170 | -$188,133 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $38,528 | $109,119 | $173,289 | $361,422 |
| End Cash | $40,876 | $38,528 | $109,119 | $173,289 |
| Free Cash Flow | -$51,937 | -$56,619 | -$71,744 | -$47,920 |